Vietnam Sanitary and Phytosanitary Notification Authority and Enquiry Point

 Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such an authorisation. In accordance with Article 7(1) of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of a preparation of Propionibacterium freudenreichii DSM 33189 and Lentilactobacillus buchneri DSM12856. That application was accompanied by the particulars and documents required under Article 7(3) of Regulation (EC) No 1831/2003. The application concerns the authorisation of the preparation of Propionibacterium freudenreichii DSM 33189 and Lentilactobacillus buchneri DSM 12856 as a feed additive for all animal species, to be classified in the additive category 'technological additives'. The European Food Safety Authority ('the Authority') concluded in its opinion of 26 January 2022 that, under the proposed conditions of use, the preparation of Propionibacterium freudenreichii DSM 33189 and Lentilactobacillus buchneri DSM 12856 does not have an adverse effect on animal health, consumer safety or the environment. It also concluded that the additive is not irritant for eyes and skin but should be considered a respiratory sensitiser and no conclusions could be drawn on the skin sensitisation potential of the additive. Therefore, the Commission considers that appropriate protective measures should be taken to prevent adverse effects on human health, in particular as regards the users of the additive. The Authority also concluded that the preparation concerned has the potential to improve the preservation of nutrients in silage prepared with easy and moderately difficult to ensile material. It also verified the report on the method of analysis of the feed additives in feed submitted by the Reference Laboratory set up by Regulation (EC) No 1831/2003. The assessment of the preparation of Propionibacterium freudenreichii DSM 33189 and Lentilactobacillus buchneri DSM12856 shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003 are satisfied. Accordingly, the use of the preparation should be authorised as specified in the Annex to this Regulation.